Mergers News
Tuesday, June 21, 2016
BRIEF-Impax signs agreements to acquire generic products from Teva, Allergan
* Expects 2016 total company revenues to increase at least
15% over full year 2015
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment